Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00176423
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Intervention: Drug: galantamine

Indicates status has not been verified in more than two years